REVASSIST

Details for Australian Trade Mark No. 1089935 (hide)

Owner Celgene Corporation a Delaware corporation

Convention US 13 September 2005 78711775

Service Banki Haddock Fiora Lawyers Level **** Street SYDNEY NSW 2000

Various Convention priority claimed: 13 September 2005, United States of America, No. 78711775 in respect of EDUCATIONAL CLASSES AND PROGRAMS AND SAFETY ISSUES PERTAINING TO PHARMACEUTICALS AND DISTRIBUTION OF WRITTEN MATERIALS THEREWITH; EDUCATIONAL CLASSES AND

Filing Date 9 December 2005

Classes

Class 41 Educational classes and programs relating to safety issues pertaining to pharmaceuticals (including in the field of the pharmaceutical lenalidomide); educational information services and information programs relating to safety issues pertaining to pharmaceuticals (including in the field of the pharmaceutical lenalidomide) and distribution of written materials therewith

Event Publications

5 January 2006 Application filed

13 April 2006 Application Accepted

10 August 2006 Trade Mark Registered/Protected

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the ATMOSS Australian Trade Mark On-line Search System.

Next and Previous Trademarks/Applications

1089936-ACDC FADINI

1089934-NAVI MATE NAVI-MATE